Precision Cancer Diagnostics

Droplex Assays - A novel solution for selecting and tailoring targeted therapies

Droplex is the diagnostic solution for identifying gene mutations across different types of cancer, thereby facilitating clinical decision-making and targeted therapy selection. By incorporating Droplet Digital^TMPCR technology, Droplex offers improved sensitivity and broader mutation coverage. Contributing to the advancement of precision medicine, the Droplex Test Series provides actionable information to choose the most promising course of treatment that is tailored to individual patients.

BIOTYPE is the exclusive distributor of the Droplex Tests for liquid biopsy targeting ESR1, PIK3CA, and EGFR in Germany and Austria. The legal manufacturer of the kits is GENCURIX, Inc.

GENCURIX Tumor Diagnostics Portfolio

Tumor Diagnostics

Droplex ESR1 Mutation Test

Detection of 16 defined mutations within the ligand-binding domain of the ESR1-gene

Tumor Diagnostics

Droplex PIK3CA Mutation Test

Detection of the 11 defined mutations within the catalytic a-subunit of the PI3K gene

Tumor Diagnostics

Droplex cMET Exon 14 Skipping Mutation Test

Detection of the Exon 14 Skipping on RNA level

Tumor Diagnostics

Droplex EGFR Mutation Test v2

Detection of the 107 defined mutations within the epidermal growth factor receptor (EGFR) gene

Tumor Diagnostics

Droplex BRAF Mutation Test v2

Detection of the 2 defined mutations within the proto-oncogene BRAF

Tumor Diagnostics

Droplex KRAS Mutation Test v2

Detection of the 28 defined mutations within the KRAS oncogene

Tumor Diagnostics

Droplex POLE Mutation Test

Detection of the 6 defined mutations within the POLE gene

Hemato-Oncology

Mentype® AMLplexQS PCR Amplification Kit

Detection of 34 transcript variants of 11 gene fusions

Related Products

Hemato-Oncology

Mentype® AMLplexQS PCR Amplification Kit

Detection of 34 transcript variants of 11 gene fusions